Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xeris Biopharma Holdings (XERS) Amortization - Intangibles (2021 - 2025)

Historic Amortization - Intangibles for Xeris Biopharma Holdings (XERS) over the last 5 years, with Q3 2025 value amounting to $2.7 million.

  • Xeris Biopharma Holdings' Amortization - Intangibles changed 0.0% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.8 million for FY2024, which is 0.0% changed from last year.
  • Per Xeris Biopharma Holdings' latest filing, its Amortization - Intangibles stood at $2.7 million for Q3 2025, which was down 0.0% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Xeris Biopharma Holdings' Amortization - Intangibles ranged from a high of $2.7 million in Q1 2022 and a low of $550000.0 during Q4 2021
  • Its 5-year average for Amortization - Intangibles is $2.6 million, with a median of $2.7 million in 2022.
  • In the last 5 years, Xeris Biopharma Holdings' Amortization - Intangibles skyrocketed by 39290.91% in 2022 and then dropped by 3.69% in 2025.
  • Quarter analysis of 5 years shows Xeris Biopharma Holdings' Amortization - Intangibles stood at $550000.0 in 2021, then soared by 392.91% to $2.7 million in 2022, then changed by 0.0% to $2.7 million in 2023, then changed by 0.0% to $2.7 million in 2024, then changed by 0.0% to $2.7 million in 2025.
  • Its Amortization - Intangibles stands at $2.7 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.7 million for Q1 2025.